PatriciaMucciLorussoDO

Clinical Trials

• Pyrazoloacridine in Treating Women With Metastatic Breast Cancer Start of enrollment: 1994 Feb 01

  Completed

  Phase 2

• KRN5500 in Treating Patients With Metastatic Solid Tumors Start of enrollment: 1997 May 01

  Completed

  Phase 1

• Fenretinide in Treating Patients With Solid Tumors Start of enrollment: 1998 May 01

  Completed

  Phase 1

• XK469 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Jan 01

  Completed

  Phase 1

• Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer Start of enrollment: 2002 Oct 01

  Completed

  Phase 1

• Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction Start of enrollment: 2004 Jul 01

  Completed

  Phase 1

• S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 2006 Sep 01

  Completed

  Phase 1

• Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors Start of enrollment: 2006 Feb 01

  Completed

• AFP464 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Jun 01

  Terminated

  Phase 1

• A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors Start of enrollment: 2005 Jan 01

  Completed

  Phase 1

• A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) Start of enrollment: 2007 Dec 14

  Active, not recruiting

  Phase 1

• FAU in Treating Patients With Advanced Solid Tumors or Lymphoma Start of enrollment: 2009 Jul 01

  Completed

  Phase 1

• Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2009 May 01

  Completed

  Not Applicable

• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Start of enrollment: 2009 Sep 01

  Suspended

  Not Applicable

• A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Start of enrollment: 2009 Dec 11

  Completed

  Phase 1

• A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas Start of enrollment: 2011 Mar 01

  Terminated

  Phase 1

• Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma Start of enrollment: 2010 Aug 06

  Completed

  Phase 2

• Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2010 Oct 01

  Completed

  Phase 1, Phase 2

• Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Jan 01

  Completed

  Phase 1

• A Study of DS-2248 in Participants With Advanced Solid Tumors Start of enrollment: 2011 Mar 29

  Terminated

  Phase 1

• Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2011 Mar 03

  Completed

  Phase 1

• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands Start of enrollment: 2011 Dec 01

  Active, not recruiting

  Phase 1

• A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors Start of enrollment: 2012 Nov 01

  Completed

  Phase 1

• Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Start of enrollment: 2013 Apr 01

  Completed

  Phase 1

• A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors Start of enrollment: 2013 Feb 01

  Completed

  Phase 1

• Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23

  Terminated

  Phase 1

• Phase 1b Trial of BGJ398/BYL719 in Solid Tumors Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies Start of enrollment: 2013 Dec 19

  Completed

  Phase 1

• A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors Start of enrollment: 2014 Jan 01

  Completed

  Phase 1

• A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors Start of enrollment: 2012 Nov 01

  Completed

  Phase 1

• Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction Start of enrollment: 2014 Mar 10

  Active, not recruiting

  Phase 1

• Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic Start of enrollment: 2014 May 01

  Completed

  Phase 2

• TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors Start of enrollment: 2014 May 20

  Active, not recruiting

  Phase 1

• Study of ASTX029 in Subjects With Advanced Solid Tumors Start of enrollment: 2018 May 10

  Active, not recruiting

  Phase 1, Phase 2

• Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas Start of enrollment: 2022 Nov 16

  Recruiting

  Phase 1, Phase 2

  Roles: Principal Investigator, Contact

• Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors Start of enrollment: 2019 Jun 13

  Active, not recruiting

  Phase 1

  Roles: Contact

• A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Jul 22

  Recruiting

  Phase 1, Phase 2

  Roles: Principal Investigator

• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17

  Active, not recruiting

  Phase 1, Phase 2

  Roles: Principal Investigator

• Join now to see all